Details of the Drug

General Information of Drug (ID: DMQ9711)

Drug Name
IONIS-GHR-LRx
Synonyms Cimdelirsen
Indication
Disease Entry ICD 11 Status REF
Acromegaly 5A60.0 Phase 2 [1]
Cross-matching ID
TTD ID
DU26QH

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Growth hormone receptor (GHR) TTKMAZ6 GHR_HUMAN Not Available [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT04522180) An Open Label, Randomized, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of IONIS-GHR-LRx, an Antisense Inhibitor of the Growth Hormone Receptor, Administered Monthly as Monotherapy in Patients With Acromegaly. U.S.National Institutes of Health.